nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLCO1A2—Chlorambucil—breast cancer	0.404	0.848	CbGbCtD
Rocuronium—SLCO1A2—Methotrexate—breast cancer	0.0723	0.152	CbGbCtD
Rocuronium—Pipecuronium—BCHE—breast cancer	0.00433	0.431	CrCbGaD
Rocuronium—Pancuronium—BCHE—breast cancer	0.00391	0.39	CrCbGaD
Rocuronium—Anaphylactoid reaction—Mitoxantrone—breast cancer	0.00189	0.00558	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Irinotecan—breast cancer	0.00189	0.00558	CcSEcCtD
Rocuronium—Bronchospasm—Vinorelbine—breast cancer	0.00189	0.00556	CcSEcCtD
Rocuronium—Anaphylactic shock—Anastrozole—breast cancer	0.00187	0.00549	CcSEcCtD
Rocuronium—Anaphylactic shock—Letrozole—breast cancer	0.00187	0.00549	CcSEcCtD
Rocuronium—Pruritus—Lapatinib—breast cancer	0.00186	0.00548	CcSEcCtD
Rocuronium—Hypotension—Ixabepilone—breast cancer	0.00185	0.00545	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Gemcitabine—breast cancer	0.00185	0.00543	CcSEcCtD
Rocuronium—Tachycardia—Letrozole—breast cancer	0.00182	0.00536	CcSEcCtD
Rocuronium—Paralysis—Methotrexate—breast cancer	0.00181	0.00533	CcSEcCtD
Rocuronium—Vecuronium—ABCB1—breast cancer	0.0018	0.18	CrCbGaD
Rocuronium—Hypersensitivity—Fulvestrant—breast cancer	0.00178	0.00525	CcSEcCtD
Rocuronium—Respiratory failure—Docetaxel—breast cancer	0.00178	0.00523	CcSEcCtD
Rocuronium—Anaphylactic shock—Idarubicin—breast cancer	0.00177	0.00522	CcSEcCtD
Rocuronium—Shock—Raloxifene—breast cancer	0.00174	0.00513	CcSEcCtD
Rocuronium—Shock—Idarubicin—breast cancer	0.00174	0.00513	CcSEcCtD
Rocuronium—Pruritus—Fulvestrant—breast cancer	0.00171	0.00504	CcSEcCtD
Rocuronium—Paralysis—Epirubicin—breast cancer	0.0017	0.00499	CcSEcCtD
Rocuronium—Hiccups—Capecitabine—breast cancer	0.00169	0.00498	CcSEcCtD
Rocuronium—Pruritus—Toremifene—breast cancer	0.00169	0.00497	CcSEcCtD
Rocuronium—Vomiting—Lapatinib—breast cancer	0.00167	0.00492	CcSEcCtD
Rocuronium—Rash—Lapatinib—breast cancer	0.00166	0.00488	CcSEcCtD
Rocuronium—Dermatitis—Lapatinib—breast cancer	0.00166	0.00488	CcSEcCtD
Rocuronium—Arrhythmia—Tamoxifen—breast cancer	0.00161	0.00473	CcSEcCtD
Rocuronium—Arrhythmia—Melphalan—breast cancer	0.00157	0.00463	CcSEcCtD
Rocuronium—Paralysis—Doxorubicin—breast cancer	0.00157	0.00462	CcSEcCtD
Rocuronium—Nausea—Lapatinib—breast cancer	0.00156	0.0046	CcSEcCtD
Rocuronium—Muscular weakness—Fluorouracil—breast cancer	0.00155	0.00456	CcSEcCtD
Rocuronium—Hypersensitivity—Exemestane—breast cancer	0.00155	0.00456	CcSEcCtD
Rocuronium—Vomiting—Fulvestrant—breast cancer	0.00154	0.00453	CcSEcCtD
Rocuronium—Arrhythmia—Goserelin—breast cancer	0.00153	0.00452	CcSEcCtD
Rocuronium—Rash—Fulvestrant—breast cancer	0.00153	0.00449	CcSEcCtD
Rocuronium—Dermatitis—Fulvestrant—breast cancer	0.00152	0.00448	CcSEcCtD
Rocuronium—Bronchospasm—Gemcitabine—breast cancer	0.00152	0.00447	CcSEcCtD
Rocuronium—Vomiting—Toremifene—breast cancer	0.00152	0.00447	CcSEcCtD
Rocuronium—Rash—Toremifene—breast cancer	0.00151	0.00443	CcSEcCtD
Rocuronium—Dermatitis—Toremifene—breast cancer	0.0015	0.00443	CcSEcCtD
Rocuronium—Pruritus—Exemestane—breast cancer	0.00149	0.00438	CcSEcCtD
Rocuronium—Apnoea—Methotrexate—breast cancer	0.00148	0.00437	CcSEcCtD
Rocuronium—Hypersensitivity—Ixabepilone—breast cancer	0.00146	0.0043	CcSEcCtD
Rocuronium—Nausea—Fulvestrant—breast cancer	0.00144	0.00423	CcSEcCtD
Rocuronium—Nausea—Toremifene—breast cancer	0.00142	0.00417	CcSEcCtD
Rocuronium—Pruritus—Ixabepilone—breast cancer	0.0014	0.00413	CcSEcCtD
Rocuronium—Hypertension—Vinblastine—breast cancer	0.00139	0.00409	CcSEcCtD
Rocuronium—Hypersensitivity—Anastrozole—breast cancer	0.00138	0.00405	CcSEcCtD
Rocuronium—Arrhythmia—Vinorelbine—breast cancer	0.00137	0.00404	CcSEcCtD
Rocuronium—Hypertension—Tamoxifen—breast cancer	0.00135	0.00398	CcSEcCtD
Rocuronium—Cardiovascular disorder—Epirubicin—breast cancer	0.00134	0.00395	CcSEcCtD
Rocuronium—Vomiting—Exemestane—breast cancer	0.00134	0.00393	CcSEcCtD
Rocuronium—Rash—Exemestane—breast cancer	0.00132	0.0039	CcSEcCtD
Rocuronium—Dermatitis—Exemestane—breast cancer	0.00132	0.0039	CcSEcCtD
Rocuronium—Pruritus—Anastrozole—breast cancer	0.00132	0.00389	CcSEcCtD
Rocuronium—Pruritus—Letrozole—breast cancer	0.00132	0.00389	CcSEcCtD
Rocuronium—Muscular weakness—Paclitaxel—breast cancer	0.00132	0.00388	CcSEcCtD
Rocuronium—Arrhythmia—Thiotepa—breast cancer	0.00131	0.00386	CcSEcCtD
Rocuronium—Hypersensitivity—Idarubicin—breast cancer	0.00131	0.00384	CcSEcCtD
Rocuronium—Hypertension—Goserelin—breast cancer	0.00129	0.0038	CcSEcCtD
Rocuronium—Respiratory failure—Methotrexate—breast cancer	0.00128	0.00377	CcSEcCtD
Rocuronium—Vomiting—Ixabepilone—breast cancer	0.00126	0.00371	CcSEcCtD
Rocuronium—Anaphylactic shock—Melphalan—breast cancer	0.00125	0.00368	CcSEcCtD
Rocuronium—Rash—Ixabepilone—breast cancer	0.00125	0.00368	CcSEcCtD
Rocuronium—Dermatitis—Ixabepilone—breast cancer	0.00125	0.00368	CcSEcCtD
Rocuronium—Nausea—Exemestane—breast cancer	0.00125	0.00367	CcSEcCtD
Rocuronium—Cardiovascular disorder—Doxorubicin—breast cancer	0.00124	0.00365	CcSEcCtD
Rocuronium—Tachycardia—Melphalan—breast cancer	0.00122	0.00359	CcSEcCtD
Rocuronium—Anaphylactic shock—Goserelin—breast cancer	0.00122	0.00359	CcSEcCtD
Rocuronium—Shock—Goserelin—breast cancer	0.0012	0.00353	CcSEcCtD
Rocuronium—Tachycardia—Goserelin—breast cancer	0.00119	0.00351	CcSEcCtD
Rocuronium—Vomiting—Letrozole—breast cancer	0.00119	0.00349	CcSEcCtD
Rocuronium—Vomiting—Anastrozole—breast cancer	0.00119	0.00349	CcSEcCtD
Rocuronium—Hiccups—Epirubicin—breast cancer	0.00118	0.00347	CcSEcCtD
Rocuronium—Nausea—Ixabepilone—breast cancer	0.00118	0.00347	CcSEcCtD
Rocuronium—Rash—Anastrozole—breast cancer	0.00118	0.00346	CcSEcCtD
Rocuronium—Rash—Letrozole—breast cancer	0.00118	0.00346	CcSEcCtD
Rocuronium—Dermatitis—Anastrozole—breast cancer	0.00118	0.00346	CcSEcCtD
Rocuronium—Dermatitis—Letrozole—breast cancer	0.00118	0.00346	CcSEcCtD
Rocuronium—Hypotension—Melphalan—breast cancer	0.00117	0.00344	CcSEcCtD
Rocuronium—Hypertension—Vinorelbine—breast cancer	0.00116	0.0034	CcSEcCtD
Rocuronium—Hypotension—Goserelin—breast cancer	0.00114	0.00336	CcSEcCtD
Rocuronium—Arrhythmia—Irinotecan—breast cancer	0.00113	0.00334	CcSEcCtD
Rocuronium—Arrhythmia—Mitoxantrone—breast cancer	0.00113	0.00334	CcSEcCtD
Rocuronium—Vomiting—Raloxifene—breast cancer	0.00113	0.00332	CcSEcCtD
Rocuronium—Vomiting—Idarubicin—breast cancer	0.00113	0.00332	CcSEcCtD
Rocuronium—Rash—Raloxifene—breast cancer	0.00112	0.00329	CcSEcCtD
Rocuronium—Rash—Idarubicin—breast cancer	0.00112	0.00329	CcSEcCtD
Rocuronium—Dermatitis—Idarubicin—breast cancer	0.00112	0.00329	CcSEcCtD
Rocuronium—Dermatitis—Raloxifene—breast cancer	0.00112	0.00329	CcSEcCtD
Rocuronium—Nausea—Anastrozole—breast cancer	0.00111	0.00326	CcSEcCtD
Rocuronium—Nausea—Letrozole—breast cancer	0.00111	0.00326	CcSEcCtD
Rocuronium—Hypertension—Thiotepa—breast cancer	0.0011	0.00325	CcSEcCtD
Rocuronium—Arrhythmia—Gemcitabine—breast cancer	0.0011	0.00325	CcSEcCtD
Rocuronium—Anaphylactic shock—Vinorelbine—breast cancer	0.00109	0.00322	CcSEcCtD
Rocuronium—Hiccups—Doxorubicin—breast cancer	0.00109	0.00321	CcSEcCtD
Rocuronium—Arrhythmia—Fluorouracil—breast cancer	0.00109	0.00319	CcSEcCtD
Rocuronium—Muscular weakness—Capecitabine—breast cancer	0.00108	0.00319	CcSEcCtD
Rocuronium—Bronchospasm—Docetaxel—breast cancer	0.00108	0.00317	CcSEcCtD
Rocuronium—Tachycardia—Vinorelbine—breast cancer	0.00107	0.00314	CcSEcCtD
Rocuronium—Asthma—Capecitabine—breast cancer	0.00106	0.00312	CcSEcCtD
Rocuronium—Hypersensitivity—Chlorambucil—breast cancer	0.00106	0.00311	CcSEcCtD
Rocuronium—Nausea—Idarubicin—breast cancer	0.00105	0.0031	CcSEcCtD
Rocuronium—Nausea—Raloxifene—breast cancer	0.00105	0.0031	CcSEcCtD
Rocuronium—Bronchospasm—Capecitabine—breast cancer	0.00104	0.00307	CcSEcCtD
Rocuronium—Hypotension—Vinorelbine—breast cancer	0.00102	0.00301	CcSEcCtD
Rocuronium—Tachycardia—Thiotepa—breast cancer	0.00102	0.003	CcSEcCtD
Rocuronium—Pruritus—Chlorambucil—breast cancer	0.00102	0.00299	CcSEcCtD
Rocuronium—Hypersensitivity—Vinblastine—breast cancer	0.000969	0.00285	CcSEcCtD
Rocuronium—Hypertension—Mitoxantrone—breast cancer	0.000953	0.00281	CcSEcCtD
Rocuronium—Hypertension—Irinotecan—breast cancer	0.000953	0.00281	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Methotrexate—breast cancer	0.000944	0.00278	CcSEcCtD
Rocuronium—Hypersensitivity—Tamoxifen—breast cancer	0.000941	0.00277	CcSEcCtD
Rocuronium—Hypertension—Gemcitabine—breast cancer	0.000929	0.00273	CcSEcCtD
Rocuronium—Arrhythmia—Paclitaxel—breast cancer	0.000924	0.00272	CcSEcCtD
Rocuronium—Hypersensitivity—Melphalan—breast cancer	0.000922	0.00271	CcSEcCtD
Rocuronium—Vomiting—Chlorambucil—breast cancer	0.000912	0.00269	CcSEcCtD
Rocuronium—Pruritus—Tamoxifen—breast cancer	0.000904	0.00266	CcSEcCtD
Rocuronium—Anaphylactic shock—Irinotecan—breast cancer	0.000901	0.00265	CcSEcCtD
Rocuronium—Anaphylactic shock—Mitoxantrone—breast cancer	0.000901	0.00265	CcSEcCtD
Rocuronium—Hypersensitivity—Goserelin—breast cancer	0.000899	0.00265	CcSEcCtD
Rocuronium—Shock—Mitoxantrone—breast cancer	0.000887	0.00261	CcSEcCtD
Rocuronium—Shock—Irinotecan—breast cancer	0.000887	0.00261	CcSEcCtD
Rocuronium—Pruritus—Melphalan—breast cancer	0.000885	0.0026	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Epirubicin—breast cancer	0.000883	0.0026	CcSEcCtD
Rocuronium—Tachycardia—Mitoxantrone—breast cancer	0.00088	0.00259	CcSEcCtD
Rocuronium—Anaphylactic shock—Gemcitabine—breast cancer	0.000878	0.00258	CcSEcCtD
Rocuronium—Pruritus—Goserelin—breast cancer	0.000863	0.00254	CcSEcCtD
Rocuronium—Anaphylactic shock—Fluorouracil—breast cancer	0.000863	0.00254	CcSEcCtD
Rocuronium—Nausea—Chlorambucil—breast cancer	0.000852	0.00251	CcSEcCtD
Rocuronium—Tachycardia—Fluorouracil—breast cancer	0.000843	0.00248	CcSEcCtD
Rocuronium—Hypotension—Mitoxantrone—breast cancer	0.000842	0.00248	CcSEcCtD
Rocuronium—Hypotension—Irinotecan—breast cancer	0.000842	0.00248	CcSEcCtD
Rocuronium—Vomiting—Vinblastine—breast cancer	0.000836	0.00246	CcSEcCtD
Rocuronium—Hypotension—Gemcitabine—breast cancer	0.00082	0.00241	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000817	0.00241	CcSEcCtD
Rocuronium—Vomiting—Tamoxifen—breast cancer	0.000812	0.00239	CcSEcCtD
Rocuronium—Hypotension—Fluorouracil—breast cancer	0.000807	0.00237	CcSEcCtD
Rocuronium—Rash—Tamoxifen—breast cancer	0.000806	0.00237	CcSEcCtD
Rocuronium—Hypersensitivity—Vinorelbine—breast cancer	0.000805	0.00237	CcSEcCtD
Rocuronium—Dermatitis—Tamoxifen—breast cancer	0.000805	0.00237	CcSEcCtD
Rocuronium—Vomiting—Melphalan—breast cancer	0.000795	0.00234	CcSEcCtD
Rocuronium—Asthma—Methotrexate—breast cancer	0.00079	0.00232	CcSEcCtD
Rocuronium—Rash—Melphalan—breast cancer	0.000789	0.00232	CcSEcCtD
Rocuronium—Dermatitis—Melphalan—breast cancer	0.000788	0.00232	CcSEcCtD
Rocuronium—Arrhythmia—Docetaxel—breast cancer	0.000783	0.00231	CcSEcCtD
Rocuronium—Nausea—Vinblastine—breast cancer	0.000781	0.0023	CcSEcCtD
Rocuronium—Hypertension—Paclitaxel—breast cancer	0.000778	0.00229	CcSEcCtD
Rocuronium—Vomiting—Goserelin—breast cancer	0.000776	0.00228	CcSEcCtD
Rocuronium—Pruritus—Vinorelbine—breast cancer	0.000773	0.00228	CcSEcCtD
Rocuronium—Rash—Goserelin—breast cancer	0.000769	0.00226	CcSEcCtD
Rocuronium—Hypersensitivity—Thiotepa—breast cancer	0.000769	0.00226	CcSEcCtD
Rocuronium—Dermatitis—Goserelin—breast cancer	0.000769	0.00226	CcSEcCtD
Rocuronium—Nausea—Tamoxifen—breast cancer	0.000759	0.00223	CcSEcCtD
Rocuronium—Arrhythmia—Capecitabine—breast cancer	0.000759	0.00223	CcSEcCtD
Rocuronium—Muscular weakness—Epirubicin—breast cancer	0.000754	0.00222	CcSEcCtD
Rocuronium—Nausea—Melphalan—breast cancer	0.000743	0.00219	CcSEcCtD
Rocuronium—Asthma—Epirubicin—breast cancer	0.000739	0.00218	CcSEcCtD
Rocuronium—Pruritus—Thiotepa—breast cancer	0.000738	0.00217	CcSEcCtD
Rocuronium—Anaphylactic shock—Paclitaxel—breast cancer	0.000735	0.00216	CcSEcCtD
Rocuronium—Nausea—Goserelin—breast cancer	0.000725	0.00213	CcSEcCtD
Rocuronium—Shock—Paclitaxel—breast cancer	0.000723	0.00213	CcSEcCtD
Rocuronium—Tachycardia—Paclitaxel—breast cancer	0.000717	0.00211	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—breast cancer	0.000698	0.00205	CcSEcCtD
Rocuronium—Vomiting—Vinorelbine—breast cancer	0.000695	0.00205	CcSEcCtD
Rocuronium—Rash—Vinorelbine—breast cancer	0.000689	0.00203	CcSEcCtD
Rocuronium—Dermatitis—Vinorelbine—breast cancer	0.000688	0.00203	CcSEcCtD
Rocuronium—Hypotension—Paclitaxel—breast cancer	0.000687	0.00202	CcSEcCtD
Rocuronium—Asthma—Doxorubicin—breast cancer	0.000684	0.00201	CcSEcCtD
Rocuronium—Hypersensitivity—Irinotecan—breast cancer	0.000664	0.00195	CcSEcCtD
Rocuronium—Hypersensitivity—Mitoxantrone—breast cancer	0.000664	0.00195	CcSEcCtD
Rocuronium—Vomiting—Thiotepa—breast cancer	0.000664	0.00195	CcSEcCtD
Rocuronium—Hypertension—Docetaxel—breast cancer	0.000659	0.00194	CcSEcCtD
Rocuronium—Rash—Thiotepa—breast cancer	0.000658	0.00194	CcSEcCtD
Rocuronium—Dermatitis—Thiotepa—breast cancer	0.000657	0.00194	CcSEcCtD
Rocuronium—Nausea—Vinorelbine—breast cancer	0.000649	0.00191	CcSEcCtD
Rocuronium—Hypertension—Capecitabine—breast cancer	0.000638	0.00188	CcSEcCtD
Rocuronium—Hypersensitivity—Fluorouracil—breast cancer	0.000636	0.00187	CcSEcCtD
Rocuronium—Anaphylactic shock—Docetaxel—breast cancer	0.000623	0.00183	CcSEcCtD
Rocuronium—Pruritus—Gemcitabine—breast cancer	0.000621	0.00183	CcSEcCtD
Rocuronium—Nausea—Thiotepa—breast cancer	0.00062	0.00182	CcSEcCtD
Rocuronium—Shock—Docetaxel—breast cancer	0.000613	0.0018	CcSEcCtD
Rocuronium—Pruritus—Fluorouracil—breast cancer	0.000611	0.0018	CcSEcCtD
Rocuronium—Tachycardia—Docetaxel—breast cancer	0.000608	0.00179	CcSEcCtD
Rocuronium—Shock—Capecitabine—breast cancer	0.000593	0.00175	CcSEcCtD
Rocuronium—Tachycardia—Capecitabine—breast cancer	0.000589	0.00173	CcSEcCtD
Rocuronium—Hypotension—Docetaxel—breast cancer	0.000582	0.00171	CcSEcCtD
Rocuronium—Vomiting—Irinotecan—breast cancer	0.000573	0.00169	CcSEcCtD
Rocuronium—Vomiting—Mitoxantrone—breast cancer	0.000573	0.00169	CcSEcCtD
Rocuronium—Rash—Irinotecan—breast cancer	0.000568	0.00167	CcSEcCtD
Rocuronium—Rash—Mitoxantrone—breast cancer	0.000568	0.00167	CcSEcCtD
Rocuronium—Dermatitis—Mitoxantrone—breast cancer	0.000568	0.00167	CcSEcCtD
Rocuronium—Dermatitis—Irinotecan—breast cancer	0.000568	0.00167	CcSEcCtD
Rocuronium—Hypotension—Capecitabine—breast cancer	0.000564	0.00166	CcSEcCtD
Rocuronium—Vomiting—Gemcitabine—breast cancer	0.000558	0.00164	CcSEcCtD
Rocuronium—Rash—Gemcitabine—breast cancer	0.000554	0.00163	CcSEcCtD
Rocuronium—Dermatitis—Gemcitabine—breast cancer	0.000553	0.00163	CcSEcCtD
Rocuronium—Vomiting—Fluorouracil—breast cancer	0.000549	0.00162	CcSEcCtD
Rocuronium—Rash—Fluorouracil—breast cancer	0.000544	0.0016	CcSEcCtD
Rocuronium—Dermatitis—Fluorouracil—breast cancer	0.000544	0.0016	CcSEcCtD
Rocuronium—Hypersensitivity—Paclitaxel—breast cancer	0.000542	0.00159	CcSEcCtD
Rocuronium—Nausea—Mitoxantrone—breast cancer	0.000535	0.00158	CcSEcCtD
Rocuronium—Nausea—Irinotecan—breast cancer	0.000535	0.00158	CcSEcCtD
Rocuronium—Arrhythmia—Epirubicin—breast cancer	0.000528	0.00156	CcSEcCtD
Rocuronium—Nausea—Gemcitabine—breast cancer	0.000522	0.00153	CcSEcCtD
Rocuronium—Pruritus—Paclitaxel—breast cancer	0.00052	0.00153	CcSEcCtD
Rocuronium—Nausea—Fluorouracil—breast cancer	0.000513	0.00151	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—breast cancer	0.000489	0.00144	CcSEcCtD
Rocuronium—Vomiting—Paclitaxel—breast cancer	0.000467	0.00138	CcSEcCtD
Rocuronium—Rash—Paclitaxel—breast cancer	0.000463	0.00136	CcSEcCtD
Rocuronium—Dermatitis—Paclitaxel—breast cancer	0.000463	0.00136	CcSEcCtD
Rocuronium—Hypersensitivity—Docetaxel—breast cancer	0.000459	0.00135	CcSEcCtD
Rocuronium—Anaphylactic shock—Methotrexate—breast cancer	0.000449	0.00132	CcSEcCtD
Rocuronium—Hypertension—Epirubicin—breast cancer	0.000445	0.00131	CcSEcCtD
Rocuronium—Hypersensitivity—Capecitabine—breast cancer	0.000444	0.00131	CcSEcCtD
Rocuronium—Pruritus—Docetaxel—breast cancer	0.000441	0.0013	CcSEcCtD
Rocuronium—Nausea—Paclitaxel—breast cancer	0.000437	0.00129	CcSEcCtD
Rocuronium—Pruritus—Capecitabine—breast cancer	0.000427	0.00126	CcSEcCtD
Rocuronium—Anaphylactic shock—Epirubicin—breast cancer	0.00042	0.00124	CcSEcCtD
Rocuronium—Hypotension—Methotrexate—breast cancer	0.00042	0.00124	CcSEcCtD
Rocuronium—Shock—Epirubicin—breast cancer	0.000413	0.00122	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—breast cancer	0.000411	0.00121	CcSEcCtD
Rocuronium—Tachycardia—Epirubicin—breast cancer	0.00041	0.00121	CcSEcCtD
Rocuronium—Vomiting—Docetaxel—breast cancer	0.000396	0.00117	CcSEcCtD
Rocuronium—Rash—Docetaxel—breast cancer	0.000393	0.00116	CcSEcCtD
Rocuronium—Hypotension—Epirubicin—breast cancer	0.000393	0.00116	CcSEcCtD
Rocuronium—Dermatitis—Docetaxel—breast cancer	0.000392	0.00116	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—breast cancer	0.000389	0.00114	CcSEcCtD
Rocuronium—Vomiting—Capecitabine—breast cancer	0.000384	0.00113	CcSEcCtD
Rocuronium—Shock—Doxorubicin—breast cancer	0.000383	0.00113	CcSEcCtD
Rocuronium—Rash—Capecitabine—breast cancer	0.00038	0.00112	CcSEcCtD
Rocuronium—Dermatitis—Capecitabine—breast cancer	0.00038	0.00112	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—breast cancer	0.00038	0.00112	CcSEcCtD
Rocuronium—Nausea—Docetaxel—breast cancer	0.00037	0.00109	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—breast cancer	0.000363	0.00107	CcSEcCtD
Rocuronium—Nausea—Capecitabine—breast cancer	0.000358	0.00105	CcSEcCtD
Rocuronium—Hypersensitivity—Methotrexate—breast cancer	0.000331	0.000974	CcSEcCtD
Rocuronium—Pruritus—Methotrexate—breast cancer	0.000318	0.000935	CcSEcCtD
Rocuronium—Hypersensitivity—Epirubicin—breast cancer	0.00031	0.000911	CcSEcCtD
Rocuronium—Pruritus—Epirubicin—breast cancer	0.000297	0.000875	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—breast cancer	0.000286	0.000843	CcSEcCtD
Rocuronium—Vomiting—Methotrexate—breast cancer	0.000286	0.00084	CcSEcCtD
Rocuronium—Rash—Methotrexate—breast cancer	0.000283	0.000833	CcSEcCtD
Rocuronium—Dermatitis—Methotrexate—breast cancer	0.000283	0.000833	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—breast cancer	0.000275	0.00081	CcSEcCtD
Rocuronium—Vomiting—Epirubicin—breast cancer	0.000267	0.000786	CcSEcCtD
Rocuronium—Nausea—Methotrexate—breast cancer	0.000267	0.000785	CcSEcCtD
Rocuronium—Rash—Epirubicin—breast cancer	0.000265	0.00078	CcSEcCtD
Rocuronium—Dermatitis—Epirubicin—breast cancer	0.000265	0.000779	CcSEcCtD
Rocuronium—Nausea—Epirubicin—breast cancer	0.00025	0.000735	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—breast cancer	0.000247	0.000728	CcSEcCtD
Rocuronium—Rash—Doxorubicin—breast cancer	0.000245	0.000722	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—breast cancer	0.000245	0.000721	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—breast cancer	0.000231	0.00068	CcSEcCtD
Rocuronium—SLCO1A2—Metabolism—SLC5A5—breast cancer	4.91e-05	0.000282	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VCP—breast cancer	4.83e-05	0.000277	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GLI2—breast cancer	4.83e-05	0.000277	CbGpPWpGaD
Rocuronium—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—breast cancer	4.81e-05	0.000276	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEPR—breast cancer	4.75e-05	0.000273	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SLC2A1—breast cancer	4.74e-05	0.000272	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NQO1—breast cancer	4.74e-05	0.000272	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—breast cancer	4.71e-05	0.000271	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MED12—breast cancer	4.71e-05	0.00027	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—DPYD—breast cancer	4.71e-05	0.00027	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CALCA—breast cancer	4.64e-05	0.000266	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	4.64e-05	0.000266	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALDOA—breast cancer	4.64e-05	0.000266	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP3A4—breast cancer	4.62e-05	0.000265	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	4.6e-05	0.000264	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1B1—breast cancer	4.54e-05	0.000261	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCR4—breast cancer	4.53e-05	0.00026	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL12—breast cancer	4.53e-05	0.00026	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—RAF1—breast cancer	4.52e-05	0.00026	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AGTR1—breast cancer	4.51e-05	0.000259	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOA3—breast cancer	4.5e-05	0.000258	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A2—breast cancer	4.47e-05	0.000257	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HSP90AA1—breast cancer	4.46e-05	0.000256	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGDIA—breast cancer	4.42e-05	0.000254	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—breast cancer	4.41e-05	0.000253	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTR—breast cancer	4.38e-05	0.000251	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCG2—breast cancer	4.38e-05	0.000251	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CPT1A—breast cancer	4.38e-05	0.000251	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOA1—breast cancer	4.33e-05	0.000249	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FST—breast cancer	4.31e-05	0.000247	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HPGDS—breast cancer	4.29e-05	0.000247	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—STK11—breast cancer	4.27e-05	0.000245	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP19A1—breast cancer	4.27e-05	0.000245	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HBA1—breast cancer	4.27e-05	0.000245	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HEY2—breast cancer	4.25e-05	0.000244	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RPS6KB2—breast cancer	4.2e-05	0.000241	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ACHE—breast cancer	4.16e-05	0.000239	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTT1—breast cancer	4.16e-05	0.000239	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RGS2—breast cancer	4.16e-05	0.000239	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL20—breast cancer	4.11e-05	0.000236	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AGTR1—breast cancer	4.1e-05	0.000235	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—ITPR1—breast cancer	4.05e-05	0.000233	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.01e-05	0.00023	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LPAR1—breast cancer	3.98e-05	0.000228	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TLE3—breast cancer	3.98e-05	0.000228	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—COMT—breast cancer	3.97e-05	0.000228	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—breast cancer	3.95e-05	0.000227	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP17A1—breast cancer	3.94e-05	0.000226	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HEY1—breast cancer	3.94e-05	0.000226	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ENO1—breast cancer	3.9e-05	0.000224	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS1—breast cancer	3.9e-05	0.000224	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HMOX1—breast cancer	3.9e-05	0.000224	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ITPR1—breast cancer	3.89e-05	0.000223	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DLL1—breast cancer	3.86e-05	0.000222	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP2D6—breast cancer	3.83e-05	0.00022	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIST1H2BK—breast cancer	3.79e-05	0.000218	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIST1H2BC—breast cancer	3.79e-05	0.000218	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRB7—breast cancer	3.76e-05	0.000216	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDE4D—breast cancer	3.76e-05	0.000216	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOA2—breast cancer	3.76e-05	0.000216	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—breast cancer	3.74e-05	0.000215	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CSF2—breast cancer	3.74e-05	0.000215	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TAB2—breast cancer	3.69e-05	0.000212	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ITPR1—breast cancer	3.68e-05	0.000211	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—TYMS—breast cancer	3.67e-05	0.000211	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CNR2—breast cancer	3.66e-05	0.00021	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CXCL8—breast cancer	3.66e-05	0.00021	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MMP3—breast cancer	3.65e-05	0.00021	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—breast cancer	3.65e-05	0.00021	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—FASN—breast cancer	3.64e-05	0.000209	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOR1—breast cancer	3.63e-05	0.000209	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PLA2G4A—breast cancer	3.63e-05	0.000209	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—breast cancer	3.63e-05	0.000209	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—BCHE—breast cancer	3.63e-05	0.000208	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC5A5—breast cancer	3.58e-05	0.000206	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DKK1—breast cancer	3.57e-05	0.000205	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFC—breast cancer	3.55e-05	0.000204	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAG2—breast cancer	3.49e-05	0.000201	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GPX1—breast cancer	3.48e-05	0.0002	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NQO1—breast cancer	3.46e-05	0.000199	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SLC2A1—breast cancer	3.46e-05	0.000199	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYP1A1—breast cancer	3.44e-05	0.000198	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—WNT1—breast cancer	3.44e-05	0.000198	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PLA2G4A—breast cancer	3.44e-05	0.000197	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ERCC2—breast cancer	3.41e-05	0.000196	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CSF2—breast cancer	3.4e-05	0.000195	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—HRAS—breast cancer	3.38e-05	0.000194	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP3A4—breast cancer	3.38e-05	0.000194	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1B1—breast cancer	3.32e-05	0.000191	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—RAF1—breast cancer	3.3e-05	0.00019	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH4—breast cancer	3.26e-05	0.000187	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSP90AA1—breast cancer	3.25e-05	0.000187	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GZMB—breast cancer	3.24e-05	0.000186	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—breast cancer	3.21e-05	0.000184	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOA1—breast cancer	3.17e-05	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL2—breast cancer	3.15e-05	0.000181	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGTR2—breast cancer	3.15e-05	0.000181	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—STK11—breast cancer	3.12e-05	0.000179	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP19A1—breast cancer	3.12e-05	0.000179	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTHLH—breast cancer	3.11e-05	0.000179	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BMP2—breast cancer	3.11e-05	0.000179	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EDNRB—breast cancer	3.02e-05	0.000173	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PGR—breast cancer	2.99e-05	0.000171	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—THBS1—breast cancer	2.97e-05	0.000171	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CAV1—breast cancer	2.96e-05	0.00017	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—COMT—breast cancer	2.9e-05	0.000167	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—breast cancer	2.89e-05	0.000166	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HMOX1—breast cancer	2.85e-05	0.000163	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ITPR1—breast cancer	2.84e-05	0.000163	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FLT1—breast cancer	2.84e-05	0.000163	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.83e-05	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SQSTM1—breast cancer	2.82e-05	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF3—breast cancer	2.82e-05	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	2.81e-05	0.000161	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAG1—breast cancer	2.79e-05	0.00016	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PARP1—breast cancer	2.78e-05	0.000159	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH3—breast cancer	2.78e-05	0.000159	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CALCA—breast cancer	2.74e-05	0.000157	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—breast cancer	2.73e-05	0.000157	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RPS6—breast cancer	2.71e-05	0.000156	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CG—breast cancer	2.7e-05	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF4—breast cancer	2.69e-05	0.000154	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TYMS—breast cancer	2.68e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCR4—breast cancer	2.68e-05	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL12—breast cancer	2.68e-05	0.000154	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—breast cancer	2.65e-05	0.000152	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PLA2G4A—breast cancer	2.65e-05	0.000152	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOR1—breast cancer	2.65e-05	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PAK1—breast cancer	2.63e-05	0.000151	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TCF7L2—breast cancer	2.58e-05	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT2—breast cancer	2.57e-05	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	2.55e-05	0.000146	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GPX1—breast cancer	2.54e-05	0.000146	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYP1A1—breast cancer	2.51e-05	0.000144	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ERCC2—breast cancer	2.49e-05	0.000143	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	2.49e-05	0.000143	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH2—breast cancer	2.49e-05	0.000143	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	2.47e-05	0.000142	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRL—breast cancer	2.42e-05	0.000139	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGTR1—breast cancer	2.42e-05	0.000139	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STK11—breast cancer	2.39e-05	0.000137	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADAM10—breast cancer	2.39e-05	0.000137	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CD—breast cancer	2.37e-05	0.000136	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLG—breast cancer	2.36e-05	0.000135	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—breast cancer	2.34e-05	0.000135	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—breast cancer	2.34e-05	0.000134	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT2—breast cancer	2.33e-05	0.000134	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF10—breast cancer	2.32e-05	0.000133	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	2.24e-05	0.000129	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFA—breast cancer	2.24e-05	0.000129	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NOS3—breast cancer	2.24e-05	0.000129	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFBR2—breast cancer	2.21e-05	0.000127	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ITPR1—breast cancer	2.17e-05	0.000125	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CAV1—breast cancer	2.16e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT5A—breast cancer	2.16e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB4—breast cancer	2.16e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP3—breast cancer	2.16e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	2.15e-05	0.000124	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SMAD4—breast cancer	2.09e-05	0.00012	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1R—breast cancer	2.08e-05	0.000119	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	2.07e-05	0.000119	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CB—breast cancer	2.07e-05	0.000119	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTGS2—breast cancer	2.05e-05	0.000118	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HES1—breast cancer	2.04e-05	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCOR1—breast cancer	2.03e-05	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	2.03e-05	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CSF2—breast cancer	2.01e-05	0.000115	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF1—breast cancer	2.01e-05	0.000115	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RAF1—breast cancer	2e-05	0.000115	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NRG1—breast cancer	1.99e-05	0.000114	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—H2AFX—breast cancer	1.98e-05	0.000114	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL2—breast cancer	1.98e-05	0.000113	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CG—breast cancer	1.97e-05	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—E2F1—breast cancer	1.96e-05	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	1.95e-05	0.000112	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPP1—breast cancer	1.89e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCL8—breast cancer	1.88e-05	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB3—breast cancer	1.87e-05	0.000107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGFR2—breast cancer	1.86e-05	0.000107	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL2—breast cancer	1.79e-05	0.000103	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TERT—breast cancer	1.79e-05	0.000103	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTEN—breast cancer	1.79e-05	0.000103	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGFR1—breast cancer	1.74e-05	9.97e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CD—breast cancer	1.73e-05	9.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HIF1A—breast cancer	1.71e-05	9.82e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—breast cancer	1.71e-05	9.82e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEP—breast cancer	1.67e-05	9.59e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CAV1—breast cancer	1.65e-05	9.5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KDR—breast cancer	1.64e-05	9.39e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NOS3—breast cancer	1.64e-05	9.39e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ESR1—breast cancer	1.59e-05	9.15e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FN1—breast cancer	1.57e-05	9.04e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NFKBIA—breast cancer	1.56e-05	8.93e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH1—breast cancer	1.54e-05	8.85e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CB—breast cancer	1.51e-05	8.67e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CG—breast cancer	1.51e-05	8.65e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—APC—breast cancer	1.51e-05	8.65e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KIT—breast cancer	1.51e-05	8.65e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTGS2—breast cancer	1.5e-05	8.59e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGF—breast cancer	1.49e-05	8.55e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MAPK3—breast cancer	1.44e-05	8.29e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BRAF—breast cancer	1.42e-05	8.13e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IGF1—breast cancer	1.38e-05	7.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT2—breast cancer	1.38e-05	7.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—EGFR—breast cancer	1.37e-05	7.88e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CD—breast cancer	1.32e-05	7.61e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	1.31e-05	7.53e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SERPINE1—breast cancer	1.31e-05	7.52e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTEN—breast cancer	1.3e-05	7.49e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—KRAS—breast cancer	1.3e-05	7.45e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CA—breast cancer	1.26e-05	7.23e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOS3—breast cancer	1.25e-05	7.18e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	1.19e-05	6.84e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MDM2—breast cancer	1.19e-05	6.81e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAF1—breast cancer	1.18e-05	6.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RELA—breast cancer	1.18e-05	6.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ERBB2—breast cancer	1.17e-05	6.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTOR—breast cancer	1.15e-05	6.63e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CB—breast cancer	1.15e-05	6.63e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL8—breast cancer	1.11e-05	6.37e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HRAS—breast cancer	1.1e-05	6.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN1B—breast cancer	1.08e-05	6.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—breast cancer	1.07e-05	6.15e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—breast cancer	1.06e-05	6.1e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL2—breast cancer	1.06e-05	6.09e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—breast cancer	1.06e-05	6.06e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCND1—breast cancer	1.03e-05	5.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUN—breast cancer	1.03e-05	5.92e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—breast cancer	1.03e-05	5.91e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CTNNB1—breast cancer	1.02e-05	5.88e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MMP9—breast cancer	1e-05	5.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1e-05	5.74e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTEN—breast cancer	9.98e-06	5.73e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK8—breast cancer	9.76e-06	5.6e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—breast cancer	9.73e-06	5.59e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SRC—breast cancer	9.25e-06	5.31e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CA—breast cancer	9.2e-06	5.28e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—breast cancer	9.01e-06	5.17e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT3—breast cancer	8.92e-06	5.12e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK3—breast cancer	8.52e-06	4.89e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MYC—breast cancer	8.29e-06	4.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFB1—breast cancer	8.27e-06	4.75e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EGFR—breast cancer	8.11e-06	4.66e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KRAS—breast cancer	7.66e-06	4.4e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—breast cancer	7.52e-06	4.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CA—breast cancer	7.04e-06	4.04e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—breast cancer	6.81e-06	3.91e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HRAS—breast cancer	6.51e-06	3.74e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—breast cancer	6.23e-06	3.58e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—breast cancer	5.75e-06	3.3e-05	CbGpPWpGaD
